Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseases.
Life Sci
; 283: 119871, 2021 Oct 15.
Article
in English
| MEDLINE | ID: covidwho-1336712
ABSTRACT
Non-communicable, chronic respiratory diseases (CRDs) affect millions of individuals worldwide. The course of these CRDs (asthma, chronic obstructive pulmonary disease, and cystic fibrosis) are often punctuated by microbial infections that may result in hospitalization and are associated with increased risk of morbidity and mortality, as well as reduced quality of life. Interleukin-13 (IL-13) is a key protein that regulates airway inflammation and mucus hypersecretion. There has been much interest in IL-13 from the last two decades. This cytokine is believed to play a decisive role in the exacerbation of inflammation during the course of viral infections, especially, in those with pre-existing CRDs. Here, we discuss the common viral infections in CRDs, as well as the potential role that IL-13 plays in the virus-induced disease pathogenesis of CRDs. We also discuss, in detail, the immune-modulation potential of IL-13 that could be translated to in-depth studies to develop IL-13-based therapeutic entities.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Interleukin-13
/
Influenza, Human
/
Lung Diseases
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Life Sci
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS